Entity Type
Company
Filer Snapshot
Review latest filings on this page
Open insider trading context
Evommune, Inc. SEC EDGAR Filings
SEC filings, ownership reports, and insider transactions for CIK 0002044725.
Total Filings
76
Latest Filing
05 Mar 2026
Industry
Pharmaceutical Preparations
Save or continue research
Save this filer for return loops, then jump into the latest filing evidence.
Save this research page
Create a free account to save this filer and follow future SEC filing updates.
- Symbol
- EVMN on NYSE
- Business address
- 1841 Page Mill Rd, Palo Alto, CA, 94304
- State of incorporation
- DE
- Fiscal year end
- 31 December
Quick Takeaways
- Evommune, Inc. is an SEC filer tracked under CIK 0002044725.
- 76 filings are listed on this profile.
- Common form coverage includes S-8, 10-K, 8-K and more.
What Changed
- Latest filing: S-8 filed on 05 Mar 2026.
- Report period: not specified in filing header.
Why This Matters
- You can quote filing dates and form types directly from the SEC record on this page.
- Use this profile before deeper ownership or insider analysis to confirm filing history context.
Official SEC Source
Filer Overview
Evommune, Inc. has filed 76 SEC EDGAR filings since 07 Jan 2025. Common forms include S-8, 10-K, 8-K, SCHEDULE 13D/A and more.
Latest Filings
Recent SEC filings for Evommune, Inc. with direct links to document and filing folders.
About this filer
Evommune, Inc. files with the SEC under CIK 0002044725. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.
FAQ
- What is a CIK?
- A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
- Why are some filings missing?
- New filings appear as the SEC updates EDGAR, and older records can vary by availability.
- How often is this page updated?
- Updates follow new EDGAR submissions and periodic data refreshes.